MedPath

Scatter Radiation Exposure During Coronary Procedures - The Occupational SCAtter Radiation Registry

Recruiting
Conditions
Coronary Artery Disease
Registration Number
NCT04945538
Lead Sponsor
Paracelsus Medical University
Brief Summary

During diagnostic and interventional coronary procedures scatter radiation exposure is recorded with live-dosimeters at pre-specified anatomic regions of operators and sterile assistants. Scatter radiation data is correlated with detailed Xray exposure data and technical details of the procedure.

The purpose of the registry is:

1. to establish scatter radiation reference values based on a large number of representative cath-lab procedures

2. to identify technical and clinical factors predisposing for high scatter radiation exposure,

3. to evaluate advanced radiation protection devices in clinical routine.

Detailed Description

Patients scheduled for diagnostic or interventional coronary procedures provide written informed consent for participating in the observational OSCAR Registry. During the corresponding procedures, scatter radiation exposure of operators and sterile assistants is recorded using Unfors RaySafe i3 digital live dosimeters (Unfors RaySafe AB, Billdal, Sweden) at 3 locations of the operator (1-frontal head at eye level, 2-left lateral head, 3-below the left shoulder) and at 2 locations of the sterile assistant (1-left neck and 2-below the left shoulder).

Raw data is collected in a central database and correlated with patient properties (age, BMI) and detailed Xray exposure data:

* Total dose-area product (DAP, unit of measure: Gy\*cm2)

* Number of Xray image series

* Number of Images

* Radiation duration (Unit of measure: Seconds)

* Air kinetic energy released per unit mass (Kerma) Technical details of the procedure

* Access site,

* Clinical setting: acute or elective

* Number of catheters used during procedure

* Number of guidewires used during procedure

* Number of stents implanted during procedure

* Cumulative stent length (Unit of measure: mm)

* Use of rotational imaging

* Use of intracoronary pressure-wire

* Use of optical coherence tomography (OCT)

* Presence of bypass-vessels

* Any occurrence of complications

The purpose of the trial is to establish a large foundation of intra-procedural scatter radiation data from representative coronary procedures procedures enabling our group to

1. Establish scatter radiation reference values based on a large number of representative cath-lab procedures

2. Identify technical and clinical factors predisposing for high staff scatter radiation exposure

3. Evaluate advanced radiation protection devices in clinical routine.

This includes:

* Additional ceiling-suspended lead-shielding

* Ceiling-suspended radiation protection devices like the "Zero-Gravity"-System (TIDI Medical Products, Neenah, WI, USA)

* Patient lead-covers.

The study was submitted to and approved by the federal Ethics Committee Salzburg (reference number ECS 1069/2021).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Patient scheduled for coronary angiography
  • Diagnostic procedure and PCI
  • Acute and elective procedures
  • Standard percutaneous coronary interventions (PCI) interventions
  • Chronic total occlusion (CTO) interventions
  • Set of at least 4 personal digital live dosimeters (PDL) worn by operator and sterile assistant for the entire duration of the procedure
  • Staff (operators and assistants) instructed on PDL positioning prior to procedure
Exclusion Criteria
  • Less than 4 PDL present during the procedure
  • Incomplete data recording by at least 1 PDL
  • PDL data cannot be unambiguously assigned to a specific procedure or a specific anatomical recording site
  • Exchange of operator or assistant during procedure without transfer of all PDL

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intra-procedural Xray scatter radiation exposure (µSv)Duration of procedure

Xray scatter radiation dose recorded by 5 personal live dosimeters (3 allocated to the operator, 2 allocated to the sterile assistant).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Paracelsus Medical University, Clinic II of Internal Medicine

🇦🇹

Salzburg, Austria

Paracelsus Medical University, Clinic II of Internal Medicine
🇦🇹Salzburg, Austria
Mathias C. Brandt, MD
Principal Investigator
Uta C. Hoppe, Prof.MD
Contact
+43-5-7255
u.hoppe@salk.at

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.